# CACI International Inc (CACI)

> Source: Nexqual · https://nexqual.com/CACI · data as of 2026-10-22 20:00 UTC · cite as "Nexqual, CACI International Inc (CACI), nexqual.com/CACI" · informational, not investment advice.

**Price:** USD 619.22 (-0.67% on the day) · last close of Oct 22, 2026; US market pre market, not a live price. Prev close 623.38 · day 609.32–640.89 · 52w 434.7–683.5 · market cap $13.7B · NYQ

## Key facts
- Last four reported quarters (through Sep 30, 2026): revenue $9.75B, net income $541M (5.5% margin), free cash flow $776M (SEC filings).
- Valuation: P/E 25.3x (avg 21.2x at the last 3 fiscal year-ends), EV/EBITDA 17.2x, net debt $4.56B.
- Insider open-market sales, last ~7 months: 1 Form 4 filings, $132K; 1 not under a Rule 10b5-1 plan ($132K); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Buy (mean 2.29 on a 1–5 scale) (17 analysts), mean target USD 744.07 (range 540–925).
- Total return with dividends: 1Y +5.9% vs S&P 500 +14.9%; 5Y +117.2% vs S&P 500 +80.3%.
- Next earnings: 2027-01-20, EPS estimate USD 7.44, revenue estimate $2.54B.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $6.20B | $6.70B | $7.66B | $8.63B | $9.57B | $9.75B |
| Operating income | $496M | $568M | $650M | $764M | $920M | $955M |
| Net income | $367M | $385M | $420M | $500M | $536M | $541M |
| EPS (diluted) | $15.49 | $16.43 | $18.60 | $22.32 | $24.16 | — |
| Free cash flow | $671M | $324M | $434M | $481M | $780M | $776M |
| Operating margin | 8.0% | 8.5% | 8.5% | 8.9% | 9.6% | 9.8% |
| Net margin | 5.9% | 5.7% | 5.5% | 5.8% | 5.6% | 5.5% |
| Revenue growth | +2.6% | +8.1% | +14.3% | +12.6% | +10.9% | — |
| Cash + short-term investments | $115M | $116M | $134M | $106M | $192M | — |
| Total debt | $1.73B | $1.70B | $1.54B | $2.92B | $4.90B | — |
Fiscal years end Jun. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Sep 30, 2026)
P/E 25.3x · P/S 1.4x · EV/EBITDA 17.2x · EV/Sales 1.9x · P/FCF 17.6x · P/B 3.0x · FCF yield 5.67% · Earnings yield 3.96% · Buyback yield (TTM) 0.13% · Net debt $4.56B · EV $18.2B
P/E at fiscal year-ends: Jun 2026 19.2x, Jun 2025 21.4x, Jun 2024 23.1x.

## Insider sales (SEC Form 4, open-market, last ~7 months)
0 of 1 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-06-16 | Gordon Susan M. | Director | 264 | $132K | 9.1% | No | Too little history (no open-market trades in 2023–2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.

## Analysts
Consensus Buy (mean 2.29 on a 1–5 scale), 17 analysts; mean target USD 744.07 (low 540, high 925).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-21 | Cantor Fitzgerald | Target raised | Overweight | $675 → $785 |
| 2026-10-16 | Macquarie | Initiated | Outperform | $780 |
| 2026-10-07 | Citigroup | Target raised | Neutral | $648 → $689 |
| 2026-10-06 | BNP Paribas | Downgrade | Neutral → Underperform | $675 → $540 |
| 2026-08-11 | Citigroup | Target raised | Neutral | $519 → $648 |
| 2026-08-07 | UBS | Target raised | Buy | $598 → $804 |
| 2026-08-07 | JP Morgan | Target raised | Overweight | $645 → $715 |
| 2026-07-07 | TD Cowen | Target lowered | Buy | $625 → $550 |
| 2026-07-01 | Jefferies | Target lowered | Hold | $550 → $510 |
| 2026-07-01 | Citigroup | Target lowered | Neutral | $555 → $519 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-18) |
|---|---|---|
| Total return | +5.9% | +117.2% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +6.0% | +16.7% |
| Volatility (annualized) | 38.5% | 31.1% |
| Max drawdown | -33.4% (Jan 2026→Jul 2026) | -42.5% (Nov 2024→Feb 2025) |

## Peers (Information Technology Services)
IT (Gartner, Inc.) USD 234.44 +6.77% · LDOS (Leidos Holdings, Inc.) USD 134.73 +4.26% · GIB (CGI Inc.) USD 82.15 +3.24% · JKHY (Jack Henry & Associates, Inc.) USD 161.8 +5.47% · WSE (Wise Group plc) USD 11.08 +0.27% · FIS (Fidelity National Information S) USD 38.29 +5.13%

## More
Full page: https://nexqual.com/CACI · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Revenue by business segment (quarter ended 2026-09-30)

| Line | Revenue | Share | YoY | Operating income | Op. margin |
|---|---|---|---|---|---|
| Domestic | $2.40B | 96.9% | +8.5% | $234.3M | 9.8% |
| International | $76.4M | 3.1% | -1.5% | $13.3M | 17.3% |
| Total revenue | $2.47B | 100% | — | $247.5M | 10.0% |

## Revenue by product line (quarter ended 2026-09-30)

| Line | Revenue | Share | YoY |
|---|---|---|---|
| Technology | $1.43B | 57.6% | +11.9% |
| Expertise | $972.9M | 39.3% | +3.9% |
| Total revenue | $2.47B | 100% | — |
The lines above cover 96.9% of total revenue.

## Company outlook (8-K filed 2026-10-21)

- "The table below summarizes our fiscal year 2027 guidance and represents our views as of October 21, 2026."

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-12-31) | $7.44 | $7.09 | +5.0% | $2.54B | 12 |
| Next quarter (ends 2027-03-31) | $8.84 | $7.69 | +14.9% | $2.75B | 12 |
| Current fiscal year (ends 2027-06-30) | $33.82 | $30.82 | +9.7% | $10.79B | 14 |
| Next fiscal year (ends 2028-06-30) | $38.11 | $35.22 | +8.2% | $11.50B | 15 |